Table 2.
Gender | Outcome | 30% reduction in smoking prevalence | 25% reduction in hypertension prevalence | 30% reduction in diabetes prevalence | 30% reduction in hyperlipidaemia prevalence |
Men | |||||
Heart disease | 10.4% (9.0 to 11.7) | 3.0% (2.1 to 3.9) | 0.7% (0.4 to 1.1) | 3.5% (2.8 to 4.3) | |
Cerebrovascular disease | 10.4% (6.3 to 14.0) | 4.0% (3.6 to 4.4) | 0.6% (0.1 to 1.1) | 1.7% (1.3 to 2.2) | |
Cardiovascular disease | 10.4% (8.2 to 12.4) | 3.3% (2.5 to 4.0) | 0.7% (0.3 to 1.1) | 3.0% (2.4 to 3.7) | |
Women | |||||
Heart disease | 1.6% (1.2 to 2.0) | 2.8% (2.1 to 3.5) | 0.7% (0.4 to 1.0) | 3.2% (2.7 to 3.8) | |
Cerebrovascular disease | 1.6% (1.1 to 2.3) | 3.5% (3.2 to 3.9) | 0.5% (0.2 to 1.0) | 1.6% (1.1 to 2.0) | |
Cardiovascular disease | 1.6% (1.2 to 2.1) | 3.1% (2.5 to 3.6) | 0.7% (0.3 to 1.0) | 2.7% (2.1 to 3.2) |